🔍

WALCHANNAG - Walchan. Inds.

📊 NSE: WALCHANNAG 🏢 Engineering 📅 Last Updated: 12/14/2025 15:14

📢 Recent Corporate Announcements

Walchandnagar Industries Shareholders Approve MD Re-appointment and Dharwad Land Sale

🟢 POSITIVE ⭐ 6/10

MANAGEMENT 📅 10 Mar 2026, 06:14 PM

Shareholders of Walchandnagar Industries have overwhelmingly approved three key resolutions via postal ballot. The company received a 99.99% approval to re-appoint Mr. Chirag C. Doshi as Managing Director & CEO for a three-year term starting April 2026. Additionally, investors approved the sale of land in Dharwad and the shifting of the company's registered office from Mumbai to Pune. These moves indicate strong shareholder support for the current leadership and strategic asset monetization.

Re-appointment of Chirag C. Doshi as MD & CEO for 3 years approved with 99.99% votes in favor
Sale of Dharwad Land (Survey nos. 71B, 72B, and 83) cleared with 99.62% shareholder approval
Registered office relocation from Mumbai to Pune approved by 99.99% of voting shares
Total of 22,687,326 valid equity shares participated in the e-voting process

💡 The management continuity and potential liquidity from the land sale are positive signs; investors should track how the proceeds from the asset sale are utilized for debt reduction or growth.

Walchandnagar Industries Shareholders Approve Land Sale and MD Re-appointment

🟢 POSITIVE ⭐ 7/10

MANAGEMENT 📅 10 Mar 2026, 03:02 PM

Walchandnagar Industries Limited has successfully passed three key special resolutions through a postal ballot process with overwhelming shareholder support (over 99% in favor for all). The company received approval to sell its Dharwad land parcels, which could potentially improve liquidity. Additionally, the registered office will shift from Mumbai to Pune, and Mr. Chirag C. Doshi has been re-appointed as MD & CEO for a three-year term starting April 2026, ensuring leadership continuity.

Sale of Dharwad land (Survey nos. 71B, 72B, and 83) approved with 99.62% votes in favor.
Re-appointment of Chirag C. Doshi as MD & CEO for a 3-year term starting April 1, 2026, passed with 99.99% approval.
Registered office relocation from Mumbai to Pune approved by 99.99% of voting shareholders.
A total of 22,687,326 valid votes were cast by 228 members during the e-voting period.

💡 Investors should monitor the financial impact of the Dharwad land sale on the company's balance sheet and debt levels. The continuity in leadership and operational shift to Pune suggests a focus on administrative efficiency.

Walchandnagar Industries Settles Dispute with Aicitta; to Recover ₹2.12 Crore

🟢 POSITIVE ⭐ 5/10

LEGAL 📅 05 Mar 2026, 04:27 PM

Walchandnagar Industries Limited (WIL) has reached an amicable settlement with Aicitta Intelligent Technology Private Limited and its promoters, resolving a dispute previously under arbitration. As per the Consent Terms signed on March 4, 2026, the company will recover a total of ₹2,12,41,096 in installments. This amount accounts for the refund of Inter-Corporate Deposits (ICD) and legal expenses incurred by WIL. Consequently, the company will exit the project and expects no negative financial impact from this settlement.

Amicable settlement reached with Aicitta Intelligent Technology and its promoters on March 4, 2026
Company to recover ₹2,12,41,096 (₹2.12 crore) in installments to settle all claims
Final installment of the recovery amount is scheduled to be paid by August 8, 2026
Recovery includes refund of Inter-Corporate Deposits (ICD) and reimbursement of legal and project expenses
Walchandnagar Industries will cease participation in the project associated with the dispute

💡 Investors should view this as a positive development as it resolves legal uncertainty and ensures the recovery of tied-up capital. Monitor the company's future filings to confirm the timely receipt of installments through August 2026.

Walchandnagar Industries to Sell Dharwad Land for ₹25 Cr and Re-appoint MD Chirag Doshi

🟢 POSITIVE ⭐ 7/10

MANAGEMENT 📅 05 Feb 2026, 07:11 PM

Walchandnagar Industries has issued a postal ballot notice seeking shareholder approval for three key resolutions. The company proposes to sell 16.42 acres of land in Dharwad, Karnataka, for a total consideration of ₹25 Crores to Manjunath B Garag Infracon Private Limited. Additionally, the board seeks to re-appoint Mr. Chirag C. Doshi as MD & CEO for a three-year term starting April 2026 with a monthly salary of ₹7 Lakhs plus allowances. The company also plans to shift its registered office from Mumbai to Pune to better align with its operational base.

Sale of 16.42 acres of land in Dharwad, Karnataka for ₹25 Crores to monetize non-core assets.
Re-appointment of Mr. Chirag C. Doshi as MD & CEO for a 3-year term effective April 1, 2026.
Proposed MD remuneration includes a monthly salary of ₹7 Lakhs and 1% commission on net profits.
Shifting of the Registered Office from Tardeo, Mumbai to Kothrud, Pune for operational efficiency.
Remote e-voting for shareholders is scheduled from February 7, 2026, to March 8, 2026.

💡 The ₹25 Crore land sale is a positive move for liquidity and potential debt reduction; investors should track how these proceeds are utilized. Leadership continuity through the MD's re-appointment suggests stability in the company's strategic direction.

Walchandnagar Industries to Sell Dharwad Land for ₹25 Crore and Re-appoint MD Chirag Doshi

🟢 POSITIVE ⭐ 7/10

MANAGEMENT 📅 05 Feb 2026, 07:03 PM

Walchandnagar Industries has issued a postal ballot notice seeking shareholder approval for three key resolutions. The company plans to sell 16.42 acres of land in Dharwad, Karnataka, for ₹25 Crores to Manjunath B Garag Infracon Private Limited. Additionally, the board has proposed the re-appointment of Mr. Chirag C. Doshi as MD & CEO for a three-year term starting April 2026. The company also intends to shift its registered office from Mumbai to Pune to optimize administrative operations.

Sale of 16.42 acres of land in Dharwad, Karnataka for a total consideration of ₹25 Crores
Re-appointment of Mr. Chirag C. Doshi as MD & CEO for 3 years effective April 1, 2026
Proposed MD remuneration includes a monthly salary of ₹7 Lakhs and a 1% commission on net profits
Shifting of the Registered Office from Tardeo, Mumbai to Kothrud, Pune
Remote e-voting period for shareholders scheduled from February 07 to March 08, 2026

💡 Investors should monitor the utilization of the ₹25 Crore land sale proceeds, which could potentially strengthen the balance sheet. The re-appointment of the MD ensures leadership stability for the company's engineering and manufacturing projects.

Walchandnagar Industries Q3 FY26 EBITDA Surges to ₹18.36 Cr; Turns PBT Positive

🟢 POSITIVE ⭐ 8/10

EARNINGS 📅 29 Jan 2026, 08:10 PM

Walchandnagar Industries reported a significant turnaround in Q3 FY26, with total revenue growing 52% QoQ to ₹84.01 crore. The company achieved a structural turnaround as EBITDA surged to ₹18.36 crore from a loss in the previous year, with margins expanding to 22%. Profit Before Tax (PBT) turned positive at ₹4.66 crore compared to a loss of ₹17.13 crore in the same quarter last year. While YTD revenues are still lower than the previous year, the quarterly performance indicates improved execution and operational efficiency.

Total Revenue increased 52% QoQ to ₹8,401 Lakhs and 35% YoY from ₹6,239 Lakhs.
EBITDA margin expanded sharply to 22% from -4% in the year-ago period.
Turned PBT positive at ₹466 Lakhs versus a loss of ₹1,713 Lakhs in Q3 FY25.
Operating leverage and cost stabilization cited as key drivers for the structural turnaround.

💡 Investors should monitor if this margin expansion is sustainable in coming quarters, as the company claims this is a structural inflection point. The stock may see positive momentum due to the return to profitability after several quarters of losses.

Walchandnagar Industries Reports No Deviation in Utilization of ₹247.59 Crore Funds

🟡 NEUTRAL ⭐ 6/10

REGULATORY 📅 29 Jan 2026, 07:34 PM

Walchandnagar Industries has submitted its statement of deviation for the quarter ended December 31, 2025, confirming that funds raised via preferential issue are being used as per stated objects. The company raised a total of ₹247.59 crores, of which ₹216 crores was received in cash and ₹31.59 crores was adjusted against promoter loans. Notably, the board approved a reallocation of ₹21 crores from Capital Expenditure to debt repayment and working capital to optimize liquidity. The monitoring agency, ICRA Limited, and the Audit Committee have reviewed and cleared the utilization report.

Total fundraise of ₹247.59 crores through fully convertible equity warrants on a preferential basis.
₹21 crores reallocated from Capital Expenditure (originally ₹105cr) to Working Capital and Loan Repayment.
₹31.59 crores successfully utilized to settle outstanding loans from promoter group entities.
₹59.96 crores spent on Capital Expenditure including plant, equipment, and building works as of Dec 2025.
ICRA Limited acting as the monitoring agency confirmed no deviations in the fund utilization process.

💡 Investors should note the reallocation of ₹21 crores from CapEx to working capital, which suggests a priority on short-term liquidity over long-term asset creation. However, the overall transparency and lack of deviations are positive signs of corporate governance.

Walchandnagar Industries Re-appoints Chirag Doshi as MD & CEO for 3 Years; Shifts Office to Pune

🟡 NEUTRAL ⭐ 6/10

MANAGEMENT 📅 29 Jan 2026, 07:14 PM

Walchandnagar Industries has approved the re-appointment of Mr. Chirag C. Doshi as Managing Director & CEO for a three-year term effective until March 31, 2029. The leadership's primary focus remains on steering the company back to profitability and achieving a long-term debt-free status. Furthermore, the company is relocating its registered office from Mumbai to Pune, which involves an amendment to the Memorandum of Association. These moves reflect a commitment to operational continuity and strategic restructuring.

Mr. Chirag C. Doshi re-appointed as MD & CEO for a 3-year term ending March 31, 2029.
Registered office shifted from Tardeo Road, Mumbai to Kothrud, Pune.
Management strategy focused on returning to profitability and becoming long-term debt-free.
Mr. Chirag Doshi, with the firm since 1997, is the son of Chairman Chakor L. Doshi.

💡 Monitor the company's progress on debt reduction and profitability targets under the continued leadership. The stability in management is a positive sign for the ongoing corporate transformation.

Walchandnagar Industries Returns to Profit in Q3 FY26 with ₹4.66 Cr PAT

🟢 POSITIVE ⭐ 7/10

EARNINGS 📅 29 Jan 2026, 06:53 PM

Walchandnagar Industries reported a significant turnaround in Q3 FY26, posting a net profit of ₹4.66 crore compared to a net loss of ₹17.13 crore in the same quarter last year. Revenue from operations grew by 37% year-on-year to ₹80.95 crore, primarily driven by strong performance in the Heavy Engineering segment. The company also successfully resumed operations at its Satara Foundry plant in late December 2025 following the withdrawal of a lockout. Additionally, finance costs saw a notable reduction, falling to ₹9.54 crore from ₹12.09 crore in the previous year's corresponding quarter.

Revenue from operations increased 37% YoY to ₹8,095 lakhs from ₹5,907 lakhs.
Reported a Net Profit of ₹466 lakhs against a Net Loss of ₹1,713 lakhs in Q3 FY25.
Heavy Engineering segment revenue grew significantly to ₹7,404 lakhs from ₹4,278 lakhs YoY.
Finance costs reduced by 21% YoY to ₹954 lakhs.
Satara Foundry plant operations resumed on December 20, 2025, after lockout withdrawal.

💡 The return to profitability and resumption of foundry operations are strong positive catalysts. Investors should watch for sustained revenue growth in the Heavy Engineering segment and further debt reduction to lower interest burdens.

Walchandnagar Industries Returns to Profit in Q3 FY26 with ₹4.66 Cr PAT; Revenue Up 37% YoY

🟢 POSITIVE ⭐ 8/10

EARNINGS 📅 29 Jan 2026, 06:49 PM

Walchandnagar Industries Limited (WIL) reported a significant financial turnaround in Q3 FY26, posting a net profit of ₹4.66 crore compared to a net loss of ₹17.13 crore in the corresponding quarter of the previous year. Revenue from operations grew by 37% YoY to ₹80.95 crore, primarily driven by the Heavy Engineering segment. The company successfully resumed operations at its Satara foundry plant in late December 2025 after a lockout withdrawal. While the company has turned profitable this quarter, it still carries a year-to-date loss of ₹17.63 crore for the nine months ended December 2025.

Turned profitable with a Net Profit of ₹466 lakhs in Q3 FY26 vs a loss of ₹1,713 lakhs in Q3 FY25.
Revenue from operations increased 37% YoY to ₹8,095 lakhs from ₹5,907 lakhs.
Heavy Engineering segment revenue surged to ₹7,404 lakhs compared to ₹4,278 lakhs in the previous year's quarter.
Foundry plant operations at Satara resumed on December 20, 2025, following the withdrawal of a lockout.
Finance costs reduced to ₹954 lakhs from ₹1,209 lakhs YoY, though they remain a significant portion of expenditure.

💡 The return to quarterly profitability and the resumption of foundry operations are strong positive indicators for a turnaround. Investors should monitor the sustainability of the Heavy Engineering segment's growth and the company's ability to further reduce high finance costs.

Walchandnagar Industries Reports 100% SDD Compliance for Q3 FY26

🟡 NEUTRAL ⭐ 3/10

ROUTINE 📅 07 Jan 2026, 02:34 PM

Walchandnagar Industries Limited has submitted its compliance certificate for the Structured Digital Database (SDD) for the quarter ended December 31, 2025. The company successfully captured 5 out of 5 required events involving Unpublished Price Sensitive Information (UPSI) during this period. The filing confirms that the database is maintained internally, is non-tamperable, and includes a full audit trail. This adherence to SEBI (Prohibition of Insider Trading) Regulations reflects the company's commitment to regulatory standards.

Successfully captured 5 out of 5 required UPSI events for the quarter ended December 31, 2025.
Maintains a non-tamperable internal database with an 8-year record retention capability.
Confirmed full compliance with SEBI (Prohibition of Insider Trading) Regulations.
Ensures controlled access and a complete audit trail for all sensitive information.

💡 This is a standard regulatory filing showing compliance with insider trading norms. Investors should focus on upcoming financial results for material performance indicators.

Walchandnagar Industries Submits Q3 FY26 SEBI Compliance Certificate for Dematerialization

🟡 NEUTRAL ⭐ 2/10

ROUTINE 📅 07 Jan 2026, 02:30 PM

Walchandnagar Industries Limited has submitted its quarterly compliance certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations for the period ending December 31, 2025. The certificate, issued by MUFG Intime India Private Limited, confirms that all securities received for dematerialization were processed and confirmed to the depositories. It further verifies that physical certificates were mutilated and cancelled after due verification within the prescribed timelines. This filing is a standard regulatory requirement to ensure the integrity of the company's electronic shareholding records.

Compliance certificate submitted for the quarter ended December 31, 2025.
Confirmation of dematerialization requests processed by MUFG Intime India Private Limited.
Verification that security certificates were mutilated and cancelled as per SEBI norms.
Ensures the register of members is updated with depository names within prescribed timelines.

💡 This is a routine administrative filing with no impact on the company's financial performance or business operations. No action is required from investors.

Walchandnagar Industries to Close Trading Window from Jan 1, 2026 for Q3 Results

🟡 NEUTRAL ⭐ 2/10

ROUTINE 📅 31 Dec 2025, 11:51 AM

Walchandnagar Industries Limited has announced the closure of its trading window for all designated persons starting January 01, 2026. This action is a standard regulatory requirement under SEBI (Prohibition of Insider Trading) Regulations, 2015, ahead of the release of financial results. The closure pertains to the un-audited financial results for the quarter and nine months ending December 31, 2025. The trading window will remain closed until 48 hours after the results are officially declared to the stock exchanges.

Trading window closure effective from January 01, 2026
Closure relates to financial results for the quarter and nine months ended December 31, 2025
Restriction applies to all designated persons as defined by the company's internal code
Window will reopen 48 hours after the declaration of the financial results
Board meeting date for result approval to be announced separately

💡 No action is required as this is a routine regulatory compliance filing. Investors should look out for the upcoming board meeting announcement to track the company's Q3 performance.

Walchandnagar Industries Clarifies Price Surge Linked to SHANTI Bill 2025 for Nuclear Sector

🟢 POSITIVE ⭐ 7/10

REGULATORY 📅 22 Dec 2025, 10:44 AM

Walchandnagar Industries responded to an NSE query regarding a significant increase in its share price, attributing the movement to the passage of the SHANTI Bill 2025. The bill, passed by Parliament on December 17 and 18, 2025, allows private sector participation in India's nuclear energy sector and revises the nuclear liability regime. As a specialized manufacturer of critical nuclear equipment, the company expects to benefit from these major policy reforms. The company clarified that there is no other undisclosed price-sensitive information and the movement is purely market-driven.

SHANTI Bill 2025 passed by Lok Sabha and Rajya Sabha on December 17 and 18, 2025
New policy allows private sector participation and reforms the nuclear liability regime in India
Walchandnagar Industries has decades of expertise in manufacturing critical equipment for nuclear plants
Company confirms no undisclosed price-sensitive information exists beyond these policy developments
Management expects the policy reform to create significant growth opportunities in the nuclear business

💡 Investors should view the SHANTI Bill as a long-term structural tailwind for the company's nuclear equipment division. While the outlook is positive, caution is advised as the recent price surge may have already factored in these regulatory developments.

Walchandnagar Industries Announces Unaudited Financial Results for Sep 2025

🟡 NEUTRAL ⭐ 6/10

EARNINGS 📅 04 Dec 2025, 01:41 PM

Walchandnagar Industries Limited's unaudited financial results for the quarter ended September 30, 2025, reveal a revenue from operations of ₹5,178 lakhs compared to ₹6,786 lakhs in the corresponding quarter of the previous year. The company reported a loss before tax of ₹1,190 lakhs for the quarter, against a loss of ₹1,102 lakhs in the same quarter last year. Basic and diluted earnings per share (EPS) stood at ₹(1.76). Investors should note the company's segment-wise performance, with Heavy Engineering revenue at ₹4,588 lakhs.

Revenue from Operations for the quarter ended September 30, 2025, was ₹5,178 lakhs.
Loss before tax for the quarter ended September 30, 2025, was ₹1,190 lakhs.
Basic and Diluted EPS for the quarter ended September 30, 2025, was ₹(1.76).
Heavy Engineering segment revenue for the quarter ended September 30, 2025, was ₹4,588 lakhs.
Total Comprehensive Income for the period is ₹(1,155) lakhs.

💡 Investors should closely monitor the company's performance in the upcoming quarters, focusing on revenue growth and profitability improvements. Pay attention to the Heavy Engineering segment's contribution to overall revenue.

View All WALCHANNAG Announcements on Live Market Tracking →

💰 Financial Performance

Revenue Growth by Segment

Total revenue for H1 FY26 was INR 109.03 Cr, a 38.3% decline from INR 176.88 Cr in H1 FY25. On a sequential basis, Q2 FY26 revenue of INR 55.42 Cr grew 2.7% over Q1 FY26. The Heavy Engineering segment showed a sequential growth of 9.0% in Q2 FY26, while the 'Others' segment grew 8.1%. The Foundry business saw a significant decline due to a lockout, generating minimal revenue.

Geographic Revenue Split

Not specifically disclosed in available documents, though the company maintains a global presence with its registered office in Mumbai, Maharashtra.

Profitability Margins

The company reported a PBT loss of INR 22.29 Cr in H1 FY26 compared to a loss of INR 16.88 Cr in H1 FY25. Net profitability is constrained by high interest costs and cost over-runs on specific orders like TNEB. Operating margins are impacted by the intensive working capital cycle and high fixed costs during periods of labor unrest.

EBITDA Margin

EBITDA margin for Q2 FY26 was 1.1% (INR 0.61 Cr) compared to 4.0% (INR 2.17 Cr) in Q1 FY26. H1 FY26 EBITDA margin stood at 2.5% (INR 2.78 Cr), a sharp decline from 6.2% (INR 10.94 Cr) in H1 FY25 due to reduced scale and loss-making segments.

Capital Expenditure

The company utilized a portion of its INR 216.00 Cr preferential issue proceeds for capex and debt prepayment. Specific planned capex includes enhancing capacity for nuclear orders and DNA business segments.

Credit Rating & Borrowing

The long-term rating is 'ACUITE BB' with the outlook revised from 'Stable' to 'Negative' as of May 2025. Short-term rating is 'ACUITE A4+'. The revision reflects a turnaround delay and weak debt protection metrics, with an Interest Coverage Ratio of -0.72x and DSCR of -0.49x in FY25.

⚙️ Operational Drivers

Raw Materials

Specialized steel, alloys, and components for nuclear and aerospace projects represent the primary material costs. Raw material delays from suppliers specifically impacted nuclear project execution in FY25.

Import Sources

Not specifically disclosed, though the company operates in high-tech manufacturing requiring specialized global and domestic sourcing.

Key Suppliers

Not disclosed by name; however, the company noted delays in raw material supply for nuclear projects from specific third-party vendors.

Capacity Expansion

Current focus is on expanding capacity for the DNA (Defence, Nuclear, Aerospace) business. The company is transitioning away from EPC to specialized OEM manufacturing to improve margins.

Raw Material Costs

Raw material costs are a significant portion of the project-based revenue. Delays in procurement and quality inspections for nuclear projects led to a decline in FY25 operating income to INR 259.18 Cr from INR 311.38 Cr in FY24.

Manufacturing Efficiency

Efficiency was severely hampered by a lockout from April 12, 2025, to November 24, 2025, and a previous 43-day strike in FY24 which cost approximately INR 30 Cr in revenue.

📈 Strategic Growth

Expected Growth Rate

15-20%

Growth Strategy

The company aims to achieve growth by focusing on the 'DNA' (Defence, Nuclear, Aerospace) sectors, targeting a healthy order book of INR 150-200 Cr in H2 FY26. Strategy includes leveraging its 116-year legacy to secure high-precision manufacturing orders for government missions and utilizing INR 216 Cr from preferential issues to deleverage and fund execution.

Products & Services

Critical equipment for Nuclear Power Plants, Aerospace components (Chandrayaan I & II), Akash Missiles, Industrial Gears, Centrifugals, Castings, and Gauges.

Brand Portfolio

Walchandnagar Industries Limited (WIL).

New Products/Services

Increased focus on specialized OEM business for Nuclear and Defence sectors, expected to be the primary driver of the positive EBITDA trajectory.

Market Expansion

Expanding presence in the strategic DNAM (Defence, Nuclear, Aerospace, Missiles) sectors to align with India's self-reliance goals.

Market Share & Ranking

Not disclosed as a specific percentage, but recognized as a key player in India's strategic heavy engineering and aerospace sectors.

🌍 External Factors

Industry Trends

The heavy engineering industry is shifting toward high-tech strategic manufacturing. WIL is positioning itself by exiting low-margin EPC and focusing on the growing DNA (Defence, Nuclear, Aerospace) market which offers better long-term visibility.

Competitive Landscape

Competes with other large-scale heavy engineering firms in India, though its niche in nuclear and aerospace precision manufacturing limits the number of direct competitors.

Competitive Moat

The moat is built on a 116-year operational legacy and specialized technical capabilities required for space and nuclear missions (e.g., Chandrayaan). These high entry barriers and long-standing government relationships provide a durable competitive advantage.

Macro Economic Sensitivity

Highly sensitive to government fiscal policy and defense spending. Inflationary pressures on raw materials and labor costs impact project profitability.

Geopolitical Risks

Beneficiary of 'Atmanirbhar Bharat' (self-reliance) initiatives in defense and nuclear sectors, which mitigates risks from global trade barriers.

⚖️ Regulatory & Governance

Industry Regulations

Operations are subject to stringent quality inspections and standards for nuclear and defense manufacturing. Compliance with SEBI (LODR) and (ICDR) regulations is monitored by ICRA.

Environmental Compliance

The company is ISO 9001:2015 certified and implements energy conservation measures like air compressor element replacement.

Legal Contingencies

A penalty of INR 21.25 Lakhs imposed by SEBI in 2015 regarding promoter entity share purchases is currently pending in the Supreme Court. A provision of INR 4.00 Cr was created for the settlement of Walchandnagar Union Agreements.

⚠️ Risk Analysis

Key Uncertainties

Labor relations remain a key risk, with past strikes and lockouts causing multi-crore revenue losses. Execution delays in long-lead nuclear projects due to supplier issues also pose a risk to the turnaround strategy.